Abstract
Six patients with biopsy-documented focal segmental glomerulosclerosis were treated with cyclosporine A (CyA) a new and potent T-cell suppressant. Dosage was adjusted to maintain trough levels between 100 and 300 ng/ml (whole blood radioimmunoassay). Patients were treated for 6 weeks or until unacceptable drug toxicity occurred. In one patient proteinuria was significantly reduced. This same individual was the only patient treated within 6 months of diagnosis. Therapy was discontinued in two patients at week 4, one because of worsening renal failure and one because of hypertension. These complications occurred despite trough CyA blood levels of less than 300 ng/ml. The results suggest that further and controlled studies of CyA are warranted in the therapy of nephrotic syndrome associated with focal segmental glomerulosclerosis, especially when used early in the course of disease. The data also suggest enhanced toxicity of CyA in patients with active nephrotic syndrome.
References
Mallick NP (1977) The pathogenesis of minimal change nephrotic syndrome. Clin Nephrol 7: 87–95
Matsumoto K, Osakabe K, Katayama H, Hatano M (1982) Concanavalin A — induced suppressor cell activity in focal glomerular sclerosis. Nephron 31: 27–30
Zimmerman SW (1984) Increased urinary protein excretion in the rat produced by serum factor from a patient with recurrent focal segmental glomerulosclerosis after renal transplantation. Clin Nephrol 22: 32–38
Habib R, Kleinknecht C (1971) The primary nephrotic syndrome of childhood: classification and clinopathologic study of 406 cases. Pathol Annu 6: 417–474
Arbus GS, Powell S, Bacheyie GS, Baumal R (1982) Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of response. J Pediatr 101: 40–45
Kanwar YS, Linker A, Farquhar MG (1980) Increased permability of the glomerular basement membrane to ferritin after the removal of glycosaminoglycans by enzyme digestion. J Cell Biol 86: 688–693
Tejani A, Butt K, Khawar R, Suthanthiran M, Rosenthal CJ, Trachtman H, Fusi M (1986) Cyclosporine induced remission of relapsing nephrotic syndrome in children. Kidney Int 29: 206
Meyrier A, Sumon P, Perret G, Loncamin MC (1986) Cyclosporine in lipoid nephrosis and focal segmental hylanosis resistant to other treatments. Kidney Int 206: 197
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waldo, F.B., Kohaut, E.C. Therapy of focal segmental glomerulosclerosis with cyclosporine A. Pediatr Nephrol 1, 180–182 (1987). https://doi.org/10.1007/BF00849292
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00849292